Patents by Inventor John W. Facemire

John W. Facemire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANEXAMIC ACID FORMULATIONS
    Publication number: 20150290127
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: June 19, 2015
    Publication date: October 15, 2015
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • TRANEXAMIC ACID FORMULATIONS
    Publication number: 20150290157
    Abstract: Disclosed are immediate release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: February 12, 2015
    Publication date: October 15, 2015
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 9060939
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: June 23, 2015
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations with reduced adverse effects
    Patent number: 8968777
    Abstract: Tranexamic acid formulated in an oral dosage form with at least one agent that decreases tranexamic acid release in the stomach. Such formulations minimize nausea, vomiting, and other adverse gastric effects that may accompany tranexamic acid therapy, for example, to treat heavy menstrual bleeding. One embodiment is an extended release formulation with waxes, polymers, etc. that prevent a bolus release of tranexamic acid in the stomach. An alternative embodiment is a delayed release formulation with polymers that prevent release of tranexamic acid in the acid environment of the stomach and delay its release until the formulation reaches the less acid environment of the intestines. Such formulations enhance patient compliance with therapy because adverse effects of tranexamic acid therapy are reduced.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: March 3, 2015
    Assignee: Ferring B.V.
    Inventors: Ralph A. Heasley, Keith A. Moore, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 8957113
    Abstract: Disclosed are immediate release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: February 17, 2015
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • TRANEXAMIC ACID FORMULATIONS
    Publication number: 20150018419
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: July 25, 2014
    Publication date: January 15, 2015
    Applicant: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 8809394
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: August 19, 2014
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 8791160
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: July 29, 2014
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 8487005
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: July 16, 2013
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20130096198
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: July 9, 2012
    Publication date: April 18, 2013
    Applicant: FERRING B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20130018100
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 17, 2013
    Applicant: FERRING B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20130012584
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: FERRING B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 8273795
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: September 25, 2012
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20120122985
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: September 13, 2011
    Publication date: May 17, 2012
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20110230559
    Abstract: Disclosed are immediate release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: January 28, 2011
    Publication date: September 22, 2011
    Applicant: FERRING B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 8022106
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: September 20, 2011
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 7947739
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: May 24, 2011
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20100143468
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: February 26, 2010
    Publication date: June 10, 2010
    Applicant: Xanodyne Pharmaceuticals, Inc.
    Inventors: Keith A. MOORE, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • TRANEXAMIC ACID FORMULATIONS
    Publication number: 20090215898
    Abstract: Disclosed are immediate release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: April 30, 2009
    Publication date: August 27, 2009
    Applicant: Xanodyne Pharmaceuticals, Inc.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • TRANEXAMIC ACID FORMULATIONS WITH REDUCED ADVERSE EFFECTS
    Publication number: 20090214644
    Abstract: Disclosed are delayed release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: April 30, 2009
    Publication date: August 27, 2009
    Applicant: Xanodyne Pharmaceuticals, Inc.
    Inventors: Ralph A. HEASLEY, Keith A. Moore, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest